Andrew D. Ashe is of Verve Therapeutics, Inc.. Currently has a direct ownership of 0 shares of VERV, which is worth approximately $0. The most recent transaction as insider was on Jul 25, 2025, when has been sold 348,828 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Andrew D. Ashe Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 25 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
348,828 Reduced 100.0%
0 Common Stock
Apr 02 2025
SELL
Open market or private sale
$11,126 $4.15 p/Share
2,681 Reduced 0.76%
348,828 Common Stock
Apr 01 2025
BUY
Exercise of conversion of derivative security
-
9,000 Added 2.5%
351,509 Common Stock
May 14 2024
BUY
Open market or private purchase
$475,760 $6.26 p/Share
76,000 Added 18.16%
342,509 Common Stock
Aug 25 2022
BUY
Exercise of conversion of derivative security
$182,953 $1.91 p/Share
95,787 Added 26.44%
266,509 Common Stock
Dec 02 2021
BUY
Open market or private purchase
$128,400 $32.1 p/Share
4,000 Added 2.29%
170,722 Common Stock
ADA

Andrew D. Ashe

Cambridge, MA

Track Institutional and Insider Activities on VERV

Follow Verve Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VERV shares.

Notify only if

Insider Trading

Get notified when an Verve Therapeutics, Inc. insider buys or sells VERV shares.

Notify only if

News

Receive news related to Verve Therapeutics, Inc.

Track Activities on VERV